Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
BLFS BioLife Solutions, Inc. daily Stock Chart
BLFS [NASD]
BioLife Solutions, Inc.
Healthcare | Medical Instruments & Supplies | USA
statements
Index- P/E34.35 EPS (ttm)0.46 Insider Own2.30% Shs Outstand21.21M Perf Week4.62%
Market Cap331.51M Forward P/E67.66 EPS next Y0.23 Insider Trans-46.02% Shs Float15.14M Perf Month2.83%
Income11.40M PEG3.44 EPS next Q-0.02 Inst Own53.50% Short Float11.67% Perf Quarter3.24%
Sales24.50M P/S13.53 EPS this Y165.80% Inst Trans1.89% Short Ratio11.90 Perf Half Y-24.78%
Book/sh3.90 P/B4.01 EPS next Y-42.68% ROA19.90% Target Price24.71 Perf Year-14.31%
Cash/sh- P/C- EPS next 5Y10.00% ROE21.70% 52W Range13.25 - 22.44 Perf YTD-3.40%
Dividend- P/FCF144.14 EPS past 5Y21.30% ROI8.50% 52W High-30.35% Beta1.37
Dividend %- Quick Ratio5.30 Sales past 5Y17.10% Gross Margin69.80% 52W Low17.96% ATR0.70
Employees54 Current Ratio6.50 Sales Q/Q24.50% Oper. Margin49.00% RSI (14)56.34 Volatility4.48% 4.52%
OptionableYes Debt/Eq0.00 EPS Q/Q655.40% Profit Margin46.50% Rel Volume0.96 Prev Close16.21
ShortableYes LT Debt/Eq0.00 EarningsMar 11 AMC Payout0.00% Avg Volume148.45K Price15.63
Recom1.60 SMA206.06% SMA500.79% SMA200-8.78% Volume141,954 Change-3.58%
Feb-19-20Initiated The Benchmark Company Buy $24
Feb-06-20Resumed B. Riley FBR Buy $27
Jan-08-20Initiated Stephens Overweight $23
Nov-21-19Initiated Oppenheimer Outperform $22
Jul-22-19Initiated H.C. Wainwright Buy $23
Nov-10-17Reiterated Maxim Group Buy $7 → $8
Sep-19-17Reiterated Maxim Group Buy $6 → $7
Jul-05-17Upgrade Janney Neutral → Buy $5
Mar-10-17Reiterated Maxim Group Buy $3 → $4
Jan-19-17Initiated Maxim Group Buy $3
Feb-17-20 06:14AM  What Does BioLife Solutions, Inc.'s (NASDAQ:BLFS) Share Price Indicate? Simply Wall St.
Feb-12-20 08:00AM  BioLife Solutions Announces Earnings Call Date and Upcoming Investor and Scientific Conferences PR Newswire
Feb-07-20 07:46AM  Analysts Back a Turnaround at BioLife Solutions Investopedia
Jan-22-20 05:46AM  Here's Why We Think BioLife Solutions (NASDAQ:BLFS) Is Well Worth Watching Simply Wall St.
Jan-04-20 07:25AM  Edited Transcript of BLFS earnings conference call or presentation 12-Nov-19 9:30pm GMT Thomson Reuters StreetEvents
Dec-30-19 11:35AM  How Much Did BioLife Solutions, Inc.'s (NASDAQ:BLFS) CEO Pocket Last Year? Simply Wall St.
Dec-26-19 08:13PM  What could you have made by investing $1,000 in these Washington companies a decade ago? American City Business Journals
Dec-19-19 09:26PM  Smart Money Dumping BioLife Solutions, Inc. (BLFS) Insider Monkey
Dec-04-19 06:58AM  Can BioLife Solutions, Inc. (NASDAQ:BLFS) Maintain Its Strong Returns? Simply Wall St.
Dec-02-19 08:00AM  BioLife Solutions Announces Executive Appointments to Support Integration of Acquired Companies PR Newswire -5.85%
Nov-22-19 03:01AM  Seattle has potential as a biotech hub, but more companies must stay here and grow American City Business Journals
Nov-12-19 04:03PM  BioLife Solutions Acquires Custom Biogenic Systems PR Newswire
04:01PM  BioLife Solutions Announces Third Quarter 2019 Financial Results PR Newswire
Nov-11-19 08:07AM  Is BioLife Solutions, Inc. (NASDAQ:BLFS) Creating Value For Shareholders? Simply Wall St.
Nov-07-19 06:15PM  BioLife Solutions, Inc. (BLFS): Hedge Fund Interest Cooling Off Insider Monkey
08:00AM  BioLife Solutions Named one of the Fastest Growing Companies in North America on Deloitte's 2019 Technology Fast 500 PR Newswire
Oct-31-19 08:23PM  BioLife Solutions to Report Third Quarter 2019 Financial Results and Provide Business Update on November 12, 2019 PR Newswire
Oct-22-19 09:13AM  Medical Products Industry Outlook: Prospects Seem Promising Zacks
Oct-14-19 09:41AM  A Quick Look at 2 Positive Looking Biotech Plays TheStreet.com +6.44%
08:00AM  BioLife Solutions Awarded Three New Patents for Cryopreservation, Thawing and Cold Chain Transport Technologies PR Newswire
Sep-24-19 08:00AM  iVexSol Announces $2M in Seed Funding GlobeNewswire -11.29%
08:00AM  BioLife Solutions Announces Cell and Gene Therapy Bioproduction Innovation Accelerator PR Newswire
Sep-16-19 08:00AM  BioLife Solutions Announces New evo® Cold Chain Customers PR Newswire
Sep-11-19 10:15PM  Biolife Solutions Inc (BLFS) President & CEO Michael Rice Sold $553,992 of Shares GuruFocus.com
Sep-06-19 10:15PM  Biolife Solutions Inc (BLFS) CFO Greef Roderick De Sold $593,400 of Shares GuruFocus.com
Sep-03-19 12:30PM  Edited Transcript of BLFS earnings conference call or presentation 8-Aug-19 8:30pm GMT Thomson Reuters StreetEvents
08:00AM  Mustang Bio Adopts CryoStor® Freeze Media and evo® Cold Chain System for Cell and Gene Therapy Manufacturing and Distribution PR Newswire
Aug-28-19 08:00AM  BioLife Solutions Strengthens Sales Team with Key Leadership Additions PR Newswire
Aug-12-19 08:00AM  BioLife Solutions to Attend and Present at Upcoming Scientific and Investor Conferences PR Newswire
Aug-08-19 11:23PM  Biolife Solutions Inc (BLFS) Q2 2019 Earnings Call Transcript Motley Fool
04:05PM  BioLife Solutions Announces Second Quarter 2019 Financial Results PR Newswire
08:05AM  BioLife Solutions Completes Acquisition of SAVSU Technologies PR Newswire
Aug-02-19 10:15PM  Biolife Solutions Inc (BLFS) CFO Greef Roderick De Sold $568,800 of Shares GuruFocus.com -5.11%
Aug-01-19 10:33AM  BioLife Solutions (BLFS) Expected to Beat Earnings Estimates: Can the Stock Move Higher? Zacks
Jul-31-19 08:00AM  BioLife Solutions to Report Second Quarter 2019 Financial Results and Provide Business Update on August 8, 2019 PR Newswire
Jul-30-19 08:00AM  SAVSU Technologies Expands IP Portfolio with Risk Mitigation Technologies for Shipping Cell and Gene Therapies PR Newswire
Jul-23-19 08:00AM  SAVSU Technologies Partners with United Cargo® to Improve Cold Chain Management and Delivery of Cell and Gene Therapies PR Newswire
Jul-08-19 04:31PM  ABQ biotech firm to be acquired American City Business Journals +15.91%
Jun-23-19 09:45PM  Hedge Funds Have Never Been This Bullish On BioLife Solutions, Inc. (BLFS) Insider Monkey
Jun-10-19 08:00AM  BioLife Solutions to Join Russell 3000® Index PR Newswire
May-30-19 08:00AM  BioLife Solutions to Present at the Jefferies 2019 Healthcare Conference PR Newswire
May-29-19 08:00AM  BioLife Solutions Announces SAVSU Technologies Selected by Novartis to Supply Advanced Cold Chain Management Platform for Newly Approved Gene Therapy PR Newswire
May-22-19 12:54PM  Edited Transcript of BLFS earnings conference call or presentation 9-May-19 8:30pm GMT Thomson Reuters StreetEvents
May-09-19 08:24PM  Biolife Solutions Inc (BLFS) Q1 2019 Earnings Call Transcript Motley Fool
04:05PM  BioLife Solutions Announces First Quarter 2019 Financial Results PR Newswire
May-02-19 10:32AM  BioLife Solutions (BLFS) to Report Q1 Results: Wall Street Expects Earnings Growth Zacks
08:00AM  BioLife Solutions to Report First Quarter 2019 Financial Results and Provide Business Update on May 9, 2019 PR Newswire
Apr-02-19 08:00AM  BioLife Solutions Completes Acquisition of Astero Bio PR Newswire
Mar-25-19 11:40AM  Can BioLife Solutions, Inc. (NASDAQ:BLFS) Improve Its Returns? Simply Wall St.
Mar-20-19 08:08AM  Edited Transcript of BLFS earnings conference call or presentation 14-Mar-19 8:30pm GMT Thomson Reuters StreetEvents
Mar-15-19 11:48PM  BioLife Solutions Inc (BLFS) Files 10-K for the Fiscal Year Ended on December 31, 2018 GuruFocus.com +5.71%
Mar-14-19 08:26PM  Biolife Solutions Inc (BLFS) Q4 2018 Earnings Conference Call Transcript Motley Fool
04:05PM  BioLife Solutions Announces Fourth Quarter and Full Year 2018 Financial Results PR Newswire
08:00AM  BioLife Solutions Expands Cell and Gene Therapy Tools Portfolio with Acquisition of Astero Bio PR Newswire
Mar-04-19 08:00AM  BioLife Solutions to Report Fourth Quarter and Full Year 2018 Financial Results and Provide Business Update on March 14, 2019 PR Newswire -10.25%
Feb-19-19 08:00AM  BioLife Solutions to Attend and Present at Upcoming Investor and Scientific Conferences PR Newswire +7.74%
Feb-08-19 08:57AM  Here's Why You Should Invest in Stryker (SYK) Stock Right Now Zacks
Jan-29-19 04:10PM  Medical Products Industry Outlook: Plenty of Upside Left Zacks
Jan-22-19 09:58AM  SAVSU Technologies Launches Two New evo® Smart Shipper Models to Improve Apheresis Collection Shipments and Cryopreserved Cell and Gene Therapies PR Newswire
08:00AM  New Policies to Advance Development of Cell and Gene Therapies Announced by FDA PR Newswire
Jan-11-19 08:53AM  Medical Products Industry Gathering Steam: 3 Stocks to Buy Zacks
Dec-11-18 08:00AM  Consolidated Research: 2018 Summary Expectations for Enbridge Energy Partners, Sprouts Farmers Market, BioLife Solutions, PagSeguro Digital, NutriSystem, and Employers Fundamental Analysis, Key Performance Indications GlobeNewswire
Dec-07-18 02:20PM  Edited Transcript of BLFS earnings conference call or presentation 8-Nov-18 9:30pm GMT Thomson Reuters StreetEvents -7.07%
Nov-27-18 08:00AM  BioLife Solutions Completes Redemption of Series A Preferred Stock PR Newswire
Nov-13-18 08:00AM  BioLife Solutions to Attend and Present at Upcoming Scientific and Investor Conferences PR Newswire
Nov-08-18 04:05PM  BioLife Solutions Announces Third Quarter 2018 Financial Results PR Newswire
Nov-05-18 08:08AM  BioLife (BLFS) to Report Q3 Earnings: What's in the Cards? Zacks
08:00AM  SAVSU Technologies to Supply evo® Cold Chain Technologies to AveXis PR Newswire
Nov-01-18 08:00AM  BioLife Solutions to Report Third Quarter 2018 Financial Results and Provide Business Update on November 8, 2018 PR Newswire
Oct-18-18 07:40AM  Market Trends Toward New Normal in Rambus, GMS, Advanced Energy Industries, AZZ, BioLife Solutions, and Spartan Motors Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
Oct-03-18 06:57AM  BioLife Solutions Sees Hammer Chart Pattern: Time to Buy? Zacks -15.87%
Oct-01-18 08:00AM  BioLife Solutions Reports Record Third Quarter 2018 Preliminary Revenue of $5.3 Million, up 79% Year-over-Year PR Newswire
Sep-27-18 09:30AM  Is BioLife Solutions (BLFS) Stock Outpacing Its Medical Peers This Year? Zacks
Sep-05-18 04:31PM  Local bioscience firm nets $5 million investment American City Business Journals -14.12%
08:00AM  BioLife Solutions Increases Ownership in SAVSU Technologies to 44% with $5 Million Investment PR Newswire
Sep-04-18 09:55AM  The Zacks Analyst Blog Highlights: Turtle Beach, BioLife Solutions, IntriCon and Medifast Zacks
Aug-31-18 08:32AM  Trump's Approval Rating Buoy Wall Street: 4 Top Gainers Zacks
Aug-30-18 08:45AM  Canopy Growth (CGC) Jumps: Stock Rises 7.4% Zacks
Aug-29-18 09:08AM  Bull Run to Continue in Rest of 2018: 5 Terrific Growth Picks Zacks
Aug-24-18 08:10AM  Factors of Influence in 2018, Key Indicators and Opportunity within Seres Therapeutics, Barnes & Noble, Carbo Ceramics, BioLife Solutions, CareDx, and Syntel New Research Emphasizes Economic Growth GlobeNewswire
Aug-22-18 08:31AM  Medtronic (MDT) Surges: Stock Moves 5.7% Higher Zacks
08:00AM  BioLife Solutions to Ring NASDAQ Closing Bell on August 29, 2018 PR Newswire
Aug-21-18 08:33AM  PetIQ (PETQ) Catches Eye: Stock Jumps 9.1% Zacks +16.00%
Aug-10-18 11:06AM  Edited Transcript of BLFS earnings conference call or presentation 9-Aug-18 2:00pm GMT Thomson Reuters StreetEvents
Aug-09-18 08:15AM  BioLife Solutions Announces Second Quarter 2018 Financial Results PR Newswire
08:05AM  Casdin Capital Invests $20 Million in BioLife Solutions to Support Strategic Growth Opportunities PR Newswire
08:00AM  BioLife Solutions, Inc. to Host Earnings Call ACCESSWIRE
Aug-06-18 09:58AM  Top Ranked Momentum Stocks to Buy for August 6th Zacks
08:00AM  BioLife Solutions to Present and Exhibit at Fall Investor and Cell & Gene Therapy Conferences PR Newswire
Aug-03-18 07:20AM  Top Ranked Momentum Stocks to Buy for August 3rd Zacks
Aug-02-18 08:00AM  BioLife Solutions to Report Second Quarter 2018 Financial Results and Provide Business Update on August 9, 2018 PR Newswire
Jul-31-18 08:03AM  SAVSU Technologies Awarded New Patent for Cold Chain Technologies Used in Cell and Gene Therapies PR Newswire +7.44%
Jul-20-18 09:30AM  Has BioLife Solutions (BLFS) Outpaced Other Medical Stocks This Year? Zacks
Jul-17-18 08:51AM  Zacks.com featured highlights include: CNX, Radcom, BioLife, Momo and Atlas Air Zacks
Jul-16-18 12:44PM  Improve Your Portfolio With These 5 Top Profitable Stocks InvestorPlace +5.91%
Jul-10-18 09:37AM  Top Ranked Momentum Stocks to Buy for July 10th Zacks
Jul-09-18 08:00AM  Sandler Capital Funds to Increase Shareholding in BioLife Solutions PR Newswire
Jul-05-18 09:51AM  Top Ranked Momentum Stocks to Buy for July 5th Zacks
09:15AM  A Short but Not So Sweet Session Zacks
Jul-03-18 10:33AM  Can The Uptrend Continue for BioLife Solutions (BLFS)? Zacks +11.41%
BioLife Solutions, Inc. develops, manufactures, and markets grade cell and tissue hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs in the United States. Its products are serum-free and protein-free solutions, which are formulated to reduce preservation-induced cell damage and death. The company offers CryoStor cryopreservation freeze media products to mitigate temperature-induced molecular cell stress responses during freezing and thawing; and HypoThermosol FRS, a hypothermic storage and shipping media product to mitigate temperature-induced molecular cell stress responses that occur during chilling and re-warming of biologics, intermediate products, and final cell products intended for research and clinical applications. It also provides BloodStor freeze media products, such as BloodStor 55-5 and BloodStor 100 to cryopreserve stem and other cells isolated from umbilical cord and peripheral blood, and bone marrow; and cell thawing media, which offers Dextran and saline for washing cryopreserved cells and tissues to dilute or remove cryoprotectants. In addition, the company provides custom product formulation and packaging services. It markets its products to the regenerative medicine, bio-banking, and drug discovery markets, including cell and gene therapy companies, research institutions, hospital-based stem cell transplant centers, cell therapy contract manufacturing organizations, contract development manufacturing organizations, pharmaceutical companies, cord blood and adult stem cell banks, and hair transplant centers, as well as suppliers of cells to the drug discovery, toxicology testing, and diagnostic markets. The company markets and sells its products directly, as well as through third party distributors. BioLife Solutions, Inc. was founded in 1987 and is headquartered in Bothell, Washington.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Rice MichaelPresident & CEOFeb 13Option Exercise2.0618,75038,625186,764Feb 13 09:36 PM
Rice MichaelPresident & CEOFeb 13Sale14.1718,750265,688168,014Feb 13 09:36 PM
Rice MichaelPresident & CEOFeb 11Option Exercise2.0618,75038,625186,764Feb 13 09:36 PM
Rice MichaelPresident & CEOFeb 11Sale13.6918,750256,688168,014Feb 13 09:36 PM
DE GREEF RODERICKCFO & COOFeb 07Option Exercise1.8110,00018,09935,859Feb 07 09:54 PM
DE GREEF RODERICKCFO & COOFeb 07Sale13.3210,000133,20025,859Feb 07 09:54 PM
DE GREEF RODERICKCFO & COOFeb 06Option Exercise1.8110,00018,09935,859Feb 07 09:54 PM
DE GREEF RODERICKCFO & COOFeb 06Sale14.4310,000144,30025,859Feb 07 09:54 PM
DE GREEF RODERICKCFO & COOFeb 05Option Exercise1.8110,00018,09935,859Feb 07 09:54 PM
Mathew Aby J.Exec VP & Chief Scientific OffFeb 05Option Exercise1.4017,96625,170200,586Feb 05 08:01 PM
DE GREEF RODERICKCFO & COOFeb 05Sale14.0610,000140,60025,859Feb 07 09:54 PM
Mathew Aby J.Exec VP & Chief Scientific OffFeb 05Sale14.0610,000140,600190,586Feb 05 08:01 PM
Mathers JamesChief Revenue OfficerFeb 04Option Exercise1.642,1133,46519,497Feb 06 08:45 PM
Mathew Aby J.Exec VP & Chief Scientific OffFeb 04Option Exercise1.4010,00014,010192,620Feb 05 08:01 PM
Mathers JamesChief Revenue OfficerFeb 04Sale14.032,11329,64517,384Feb 06 08:45 PM
Mathew Aby J.Exec VP & Chief Scientific OffFeb 04Sale14.1010,000141,000182,620Feb 05 08:01 PM
Mathew Aby J.Exec VP & Chief Scientific OffFeb 03Option Exercise1.4010,00014,010192,620Feb 05 08:01 PM
Mathew Aby J.Exec VP & Chief Scientific OffFeb 03Sale13.6310,000136,300182,620Feb 05 08:01 PM
GIRSCHWEILER THOMASDirectorJan 30Option Exercise1.4010,71415,0101,524,677Feb 03 08:39 PM
Mathers JamesChief Revenue OfficerJan 23Option Exercise1.642,5004,10019,884Jan 23 08:05 PM
Mathers JamesChief Revenue OfficerJan 23Sale15.112,50037,77517,384Jan 23 08:05 PM
Mathers JamesChief Revenue OfficerJan 22Option Exercise1.642,5004,10019,884Jan 23 08:05 PM
Mathers JamesChief Revenue OfficerJan 22Sale15.682,50039,20017,384Jan 23 08:05 PM
Mathers JamesChief Revenue OfficerJan 21Option Exercise1.642,5004,10019,884Jan 23 08:05 PM
Mathers JamesChief Revenue OfficerJan 21Sale15.692,50039,22517,384Jan 23 08:05 PM
Mathers JamesChief Revenue OfficerJan 09Option Exercise1.642,5004,10019,884Jan 09 08:01 PM
Mathers JamesChief Revenue OfficerJan 09Sale16.762,50041,90017,384Jan 09 08:01 PM
DE GREEF RODERICKCFO & COOJan 08Option Exercise1.7610,00017,60035,859Jan 08 08:00 PM
Mathers JamesChief Revenue OfficerJan 08Option Exercise1.642,5004,10019,884Jan 09 08:01 PM
DE GREEF RODERICKCFO & COOJan 08Sale16.1610,000161,60025,859Jan 08 08:00 PM
Mathers JamesChief Revenue OfficerJan 08Sale16.052,50040,12517,384Jan 09 08:01 PM
DE GREEF RODERICKCFO & COOJan 07Option Exercise1.7610,00017,60035,859Jan 08 08:00 PM
Mathers JamesChief Revenue OfficerJan 07Option Exercise1.642,5004,10019,884Jan 09 08:01 PM
DE GREEF RODERICKCFO & COOJan 07Sale15.4610,000154,60025,859Jan 08 08:00 PM
Mathers JamesChief Revenue OfficerJan 07Sale15.732,50039,32517,384Jan 09 08:01 PM
DE GREEF RODERICKCFO & COOJan 06Option Exercise1.7610,00017,60035,859Jan 08 08:00 PM
DE GREEF RODERICKCFO & COOJan 06Sale15.9010,000159,00025,859Jan 08 08:00 PM
Mathers JamesChief Revenue OfficerDec 27Option Exercise1.642,5004,10019,884Dec 27 08:00 PM
Mathers JamesChief Revenue OfficerDec 27Sale16.612,50041,52517,384Dec 27 08:00 PM
Mathers JamesChief Revenue OfficerDec 26Option Exercise1.642,5004,10019,884Dec 27 08:00 PM
Mathers JamesChief Revenue OfficerDec 26Sale16.512,50041,27517,384Dec 27 08:00 PM
Mathers JamesChief Revenue OfficerDec 24Option Exercise1.642,5004,10019,884Dec 27 08:00 PM
Mathers JamesChief Revenue OfficerDec 24Sale16.402,50041,00017,384Dec 27 08:00 PM
Berard ToddChief Marketing OfficerDec 16Option Exercise2.063,0006,18044,074Dec 18 08:00 PM
Berard ToddChief Marketing OfficerDec 16Sale15.683,00047,04041,074Dec 18 08:00 PM
Rice MichaelPresident & CEODec 12Option Exercise1.1210,24711,477178,261Dec 12 08:27 PM
Mathers JamesChief Revenue OfficerDec 12Option Exercise1.642,5004,10019,884Dec 12 09:17 PM
Rice MichaelPresident & CEODec 12Sale15.1110,247154,832168,014Dec 12 08:27 PM
Mathers JamesChief Revenue OfficerDec 12Sale15.002,50037,50017,384Dec 12 09:17 PM
Mathers JamesChief Revenue OfficerDec 11Option Exercise1.642,5004,10019,884Dec 12 09:17 PM
Mathers JamesChief Revenue OfficerDec 11Sale15.082,50037,70017,384Dec 12 09:17 PM
Rice MichaelPresident & CEODec 10Option Exercise1.1210,00011,200178,014Dec 12 08:27 PM
Mathers JamesChief Revenue OfficerDec 10Option Exercise1.642,5004,10019,884Dec 12 09:17 PM
Rice MichaelPresident & CEODec 10Sale15.3710,000153,700168,014Dec 12 08:27 PM
Mathers JamesChief Revenue OfficerDec 10Sale15.652,50039,12517,384Dec 12 09:17 PM
DE GREEF RODERICKChief Financial OfficerDec 06Option Exercise1.7610,00017,60035,859Dec 06 08:01 PM
DE GREEF RODERICKChief Financial OfficerDec 06Sale16.2110,000162,10025,859Dec 06 08:01 PM
DE GREEF RODERICKChief Financial OfficerDec 05Option Exercise1.7610,00017,60035,859Dec 06 08:01 PM
DE GREEF RODERICKChief Financial OfficerDec 05Sale16.1910,000161,90025,859Dec 06 08:01 PM
DE GREEF RODERICKChief Financial OfficerDec 04Option Exercise1.7610,00017,60035,859Dec 06 08:01 PM
DE GREEF RODERICKChief Financial OfficerDec 04Sale16.0110,000160,10025,859Dec 06 08:01 PM
Mathers JamesVice President, Global SalesNov 29Option Exercise1.642,5004,10019,884Nov 29 08:00 PM
Mathers JamesVice President, Global SalesNov 29Sale16.332,50040,82517,384Nov 29 08:00 PM
Mathers JamesVice President, Global SalesNov 27Option Exercise1.642,5004,10019,884Nov 29 08:00 PM
Mathers JamesVice President, Global SalesNov 27Sale16.272,50040,67517,384Nov 29 08:00 PM
Mathers JamesVice President, Global SalesNov 26Option Exercise1.642,5004,10019,884Nov 29 08:00 PM
Mathers JamesVice President, Global SalesNov 26Sale16.522,50041,30017,384Nov 29 08:00 PM
Casdin Partners Master Fund, L10% OwnerNov 20Buy15.6820,000313,6182,468,571Nov 21 12:52 PM
Casdin Partners Master Fund, L10% OwnerNov 19Buy15.1520,000302,9182,448,571Nov 21 12:52 PM
Berard ToddV.P. MarketingNov 14Option Exercise2.063,0006,18044,074Nov 14 08:01 PM
Mathers JamesVice President, Global SalesNov 14Option Exercise1.642,5004,10019,884Nov 14 08:01 PM
Rice MichaelPresident & CEONov 14Option Exercise1.1210,00011,200185,014Nov 14 08:00 PM
Berard ToddV.P. MarketingNov 14Sale14.063,00042,18041,074Nov 14 08:01 PM
Mathers JamesVice President, Global SalesNov 14Sale14.062,50035,15017,384Nov 14 08:01 PM
Rice MichaelPresident & CEONov 14Sale13.9810,000139,800175,014Nov 14 08:00 PM
Mathers JamesVice President, Global SalesNov 13Option Exercise1.642,5004,10019,884Nov 14 08:01 PM
Mathers JamesVice President, Global SalesNov 13Sale15.572,50038,92517,384Nov 14 08:01 PM
Mathers JamesVice President, Global SalesNov 12Option Exercise1.642,5004,10019,884Nov 14 08:01 PM
Rice MichaelPresident & CEONov 12Option Exercise1.1210,00011,200185,014Nov 14 08:00 PM
Mathers JamesVice President, Global SalesNov 12Sale16.692,50041,72517,384Nov 14 08:01 PM
Rice MichaelPresident & CEONov 12Sale16.7810,000167,800175,014Nov 14 08:00 PM
DE GREEF RODERICKChief Financial OfficerNov 08Option Exercise1.7610,00017,60035,859Nov 08 08:00 PM
DE GREEF RODERICKChief Financial OfficerNov 08Sale16.4410,000164,40025,859Nov 08 08:00 PM
DE GREEF RODERICKChief Financial OfficerNov 07Option Exercise1.7610,00017,60035,859Nov 08 08:00 PM
DE GREEF RODERICKChief Financial OfficerNov 07Sale17.0810,000170,80025,859Nov 08 08:00 PM
DE GREEF RODERICKChief Financial OfficerNov 06Option Exercise1.6410,00016,40035,859Nov 08 08:00 PM
DE GREEF RODERICKChief Financial OfficerNov 06Sale17.8110,000178,10025,859Nov 08 08:00 PM
Mathers JamesVice President, Global SalesOct 31Option Exercise1.642,5004,10019,884Oct 31 08:00 PM
Mathers JamesVice President, Global SalesOct 31Sale16.892,50042,22517,384Oct 31 08:00 PM
Mathers JamesVice President, Global SalesOct 30Option Exercise1.642,5004,10019,884Oct 31 08:00 PM
Mathers JamesVice President, Global SalesOct 30Sale17.442,50043,60017,384Oct 31 08:00 PM
Hinson Andrew GDirectorOct 30Sale17.876,000107,22014,461Oct 31 08:28 PM
Mathers JamesVice President, Global SalesOct 29Option Exercise1.642,5004,10019,884Oct 31 08:00 PM
Mathers JamesVice President, Global SalesOct 29Sale17.312,50043,27517,384Oct 31 08:00 PM
Rice MichaelPresident & CEOOct 17Option Exercise1.1210,00011,200185,014Oct 17 09:14 PM
Mathers JamesVice President, Global SalesOct 17Option Exercise1.642,6934,41720,077Oct 17 09:16 PM
Rice MichaelPresident & CEOOct 17Sale16.2610,000162,600175,014Oct 17 09:14 PM
Mathers JamesVice President, Global SalesOct 17Sale16.422,69344,21920,077Oct 17 09:16 PM
Mathers JamesVice President, Global SalesOct 16Option Exercise1.642,3073,78319,691Oct 17 09:16 PM
Mathers JamesVice President, Global SalesOct 16Sale16.032,30736,98117,384Oct 17 09:16 PM
open in yahoo | open in reuters | open in google